Rebecca Burdine is a faculty member in the Department of Molecular Biology at Princeton University. Her lab focuses on understanding the developmental mechanisms that control left-right patterning and organ morphogenesis in order to understanding how structure birth anomalies arise. She was named the 44th Mallinckrodt Scholar for the Edward Mallinckrodt Jr. Foundation, and received a Scientist Development Career Award from the American Heart Association in 2003. She was elected as fellow to the American Association for the Advancement of Science (AAAS) in 2018. She is currently serving on the Board of The International Society of Differentiation, and previously served on the boards of the Genetics Society of America and the International Zebrafish Society. She is on the Editorial board for Zebrafish, and regularly serves on grant review panels for the NIH and NSF. 

Dr. Burdine graduated summa cum laude from Western Kentucky University, majoring in Recombinant Gene Technology with a minor in Chemistry. She received her Ph.D. from Yale University for her thesis work with Dr. Michael Stern. Dr. Burdine carried out her postdoctoral research in the laboratory of Alexander F. Schier (Harvard) when he was at the Skirball Institute of Biomolecular Medicine at New York University. 

Dr. Burdine is a parent to a child with Angelman Syndrome. She first served on the Angelman Syndrome Foundation (ASF) scientific advisory committee in 2007 by invitation from Dr. Joe Wagstaff. She has previously served as Chief Scientific Officer for the Pitt-Hopkins Research Foundation and for the Foundation for Angelman Syndrome Therapeutics. She is currently serving on the Board of Directors and the Chair of the Science Advisory Committee for the ASF.
 

Teaching

MOL 506: Cell and Developmental Biology (Graduate)

MOL 348: Cell and Developmental Biology (Undergraduate)